A detailed history of Voya Investment Management LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 112,897 shares of NUVL stock, worth $8.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
112,897
Previous 110,459 2.21%
Holding current value
$8.97 Million
Previous $11.3 Million 21.79%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$77.87 - $104.93 $189,847 - $255,819
2,438 Added 2.21%
112,897 $8.84 Million
Q3 2024

Feb 07, 2025

SELL
$67.44 - $112.17 $5.33 Million - $8.87 Million
-79,104 Reduced 41.73%
110,459 $11.3 Million
Q3 2024

Nov 14, 2024

SELL
$67.44 - $112.17 $5.36 Million - $8.92 Million
-79,525 Reduced 42.54%
107,399 $11 Million
Q2 2024

Feb 07, 2025

SELL
$62.76 - $81.61 $2.42 Million - $3.15 Million
-38,552 Reduced 16.9%
189,563 $14.4 Million
Q2 2024

Dec 03, 2024

BUY
$62.76 - $81.61 $4.99 Million - $6.49 Million
79,525 Added 74.05%
186,924 $14.2 Million
Q2 2024

Aug 14, 2024

SELL
$62.76 - $81.61 $2.59 Million - $3.36 Million
-41,191 Reduced 18.06%
186,924 $14.2 Million
Q1 2024

Feb 07, 2025

BUY
$72.35 - $88.99 $8.73 Million - $10.7 Million
120,716 Added 112.4%
228,115 $17.1 Million
Q1 2024

Dec 06, 2024

BUY
$72.35 - $88.99 $8.73 Million - $10.7 Million
120,716 Added 112.4%
228,115 $17.1 Million
Q1 2024

May 15, 2024

BUY
$72.35 - $88.99 $10.2 Million - $12.6 Million
141,408 Added 163.09%
228,115 $17.1 Million
Q4 2023

Feb 07, 2025

BUY
$42.42 - $80.28 $3.27 Million - $6.19 Million
77,077 Added 800.38%
86,707 $6.38 Million
Q4 2023

Feb 14, 2024

BUY
$42.42 - $80.28 $3.27 Million - $6.19 Million
77,077 Added 800.38%
86,707 $6.38 Million
Q3 2023

Feb 07, 2025

BUY
$39.12 - $49.85 $4,577 - $5,832
117 Added 1.23%
9,630 $442,000
Q3 2023

Nov 14, 2023

BUY
$39.12 - $49.85 $4,577 - $5,832
117 Added 1.23%
9,630 $442,000
Q2 2023

Feb 07, 2025

SELL
$23.58 - $44.68 $2.31 Million - $4.37 Million
-97,886 Reduced 91.14%
9,513 $401,000
Q2 2023

Aug 14, 2023

BUY
$23.58 - $44.68 $224,316 - $425,040
9,513 New
9,513 $401,000
Q4 2022

Feb 07, 2025

SELL
$18.46 - $36.37 $1.84 Million - $3.63 Million
-99,833 Reduced 92.96%
7,566 $225,000
Q4 2022

Feb 14, 2023

BUY
$18.46 - $36.37 $139,668 - $275,175
7,566 New
7,566 $225,000

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.42B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.